In this mini-review, we briefly describe recent progress in understanding MYC control by the ubiquitin proteasome system including novel ubiquitin ligases and deubiquitinating enzymes and then focus on the perspectives of targeting these molecules for cancer therapy. This evidence concerns the gene MYC and cancer.